Factors predicting the success of ejaculation preserving transurethral resection of the prostate: a prospective cohort study Authors: Ahmed Higazy, Marco Sawiris, Mohamed Kotb, Mohamed Ismail, Ahmed Tawfick, Ahmed Lotfy Published: 2026 ABSTRACT BackgroundThe objective of this study was to evaluate the clinical and anatomical factors predicting the preservation of antegrade ejaculation following ejaculation-preserving transurethral resection of the prostate (EP-TURP).Materials and methodsThis prospective cohort study included sexually active men undergoing EP-TURP. Preoperative evaluation included the International Prostate Symptom Score, quality of life, and assessment of ejaculatory function using the Male Sexual Health Questionnaire–Ejaculatory Dysfunction Short Form. Transrectal ultrasonography was used to evaluate prostate size, intravesical prostatic protrusion, supramontanal length, and the presence of a median lobe. The surgical technique involved preserving 1 cm of circumferential urethral mucosa around the verumontanum while performing standard bipolar TURP. Patients were followed up at 3 months postoperatively. Multivariable regression analysis was used to identify predictors of ejaculation preservation.ResultsA total of 108 patients were included in the final analysis. Significant improvements were observed in postoperative voiding parameters (P < 0.001). Antegrade ejaculation was preserved in 63 patients (58.3%). Preservation was significantly higher in patients with a prostate size <80 g than in those with a prostate size ≥80 g (81.1% vs 36.4%). On multivariable analysis, larger prostate volume (odds ratio [OR]: 0.97, 95% confidence interval [CI]: 0.95–0.99, P = 0.018), increased intravesical prostatic protrusion (OR: 0.75, 95% CI: 0.56–0.99, P = 0.023), and the presence of a median lobe (OR: 0.73, 95% CI: 0.54–0.99, P = 0.048) were independently associated with a lower odds of ejaculation preservation.ConclusionsEP-TURP provides significant improvement in voiding parameters while preserving antegrade ejaculation in a substantial proportion of patients. Larger prostate size, significant intravesical prostatic protrusion, and median lobe enlargement are associated with lower preservation rates and should be considered during patient selection and preoperative counseling. Introduction Benign prostatic hyperplasia (BPH) is a major cause of lower urinary tract symptoms in aging men. Transurethral resection of the prostate (TURP) remains the standard surgical management for patients with bladder outlet obstruction refractory to medical therapy. Although conventional TURP provides durable improvement in voiding function, it is commonly associated with retrograde ejaculation, reported in 65–90% of sexually active men. Loss of antegrade ejaculation may negatively affect the quality of life (QoL), especially in young and sexually active patients.1, 2, 3, 4 Based on a better understanding of the anatomical and physiological processes of ejaculation as described by Vernet et al, maintaining the high-pressure chamber through the caudal shift of the verumontanum to the adjacent urethral wall is crucial for antegrade ejaculation. Several surgical techniques for ejaculation-preserving TURP (EP-TURP) have been described in the literature, with heterogeneous data regarding patients’ characteristics, tissue preservation technique, and success rate.5, 6, 7 Despite these promising results, not all patients undergoing EP-TURP maintain antegrade ejaculation. Existing studies have primarily focused on describing the surgical technique and overall efficacy, with limited emphasis on identifying independent predictors of successful ejaculation preservation.8, 9, 10, 11, 12 The present study aims to evaluate the factors predicting the success of ejaculation preservation following EP-TURP by assessing clinical and anatomical characteristics, using the same surgical technique for EP-TURP to enable better patient selection, counseling, and further advances in functional outcomes in the endoscopic surgical management of BPH. Materials and methods Study design and population This prospective cohort study was conducted at a tertiary urology center. Sexually active men with normal preoperative ejaculatory function who were candidates for surgical management of benign prostatic obstruction, including failure of medical therapy, chronic urinary retention, recurrent hematuria, recurrent urinary tract infections, or upper urinary tract affection, were eligible for inclusion regardless of their age. Exclusion criteria included patients with anterior urethral stricture, prior urethral or prostatic surgery, and/or neurologic disorders affecting voiding or ejaculation and nonsexually active patients. The study protocol was approved by the local institutional review board with an approval number MS 397/2025. The trial was registered at Clinicaltrials.gov, with a registration number NCT07513896. Written informed consent was obtained from all participants. Sample size calculation was performed using PASS software with a type I error (α) of 0.05 and a 20% margin of error. Based on the findings of Tawfeek et al,10 which reported preservation of ejaculation in 83% of cases following EP-TURP, the minimum required sample size was calculated to be 55 patients. However, during the study period, 111 eligible patients were prospectively recruited to compensate for potential loss to follow-up and to strengthen the reliability of the multivariable regression analysis. Preoperative evaluation All patients underwent detailed history taking, including the International Prostate Symptom Score, QoL, and the Male Sexual Health Questionnaire for Ejaculatory Dysfunction Short Form. Physical examination included abdominal examination and digital rectal examination. Laboratory investigations included kidney function tests, prostate-specific antigen level, and urine culture to exclude any urinary tract infection prior to enrollment. Pelvic-abdominal ultrasonography was performed to assess prostate volume and postvoid residual urine. Transrectal ultrasound was used to evaluate prostate configuration, the presence of a median lobe, intravesical prostatic protrusion (IPP), and supramontanal length (SML). Surgical technique In our study, we performed an EP-TURP technique, which is adopted in our institution and involves the preservation of 1 cm of urethral mucosa circumferentially around the verumontanum, including the prostatic apical urethral mucosa, with adequate resection of the prostatic adenoma, including the apical prostatic tissue, which was resected lateral to the spared urethral mucosa to ensure adequate management of the outflow obstruction.10 Bipolar TURP was performed using a 26-Fr resectoscope (Karl Storz, Tuttlingen, Germany) and the Karl Storz AUTOCON® IV. Intraoperative cystoscopic evaluation and documentation of the prostatic anatomy were performed. SML was measured cystoscopically using a 22-Fr sheath with centimeter markings. Operative time, perioperative complications, catheterization duration, and hospital stay were recorded. Urethral catheter removal was planned after 24–48 hours unless prolonged catheterization was clinically indicated. Follow-up and outcomes Patients were evaluated at 3 months postoperatively. Assessments included both voiding and ejaculation function: the International Prostate Symptom Score, QoL, and Male Sexual Health Questionnaire for Ejaculatory Dysfunction Short Form questionnaires. Uroflowmetry and ultrasonography were performed to assess voiding parameters and residual urine. The primary outcome was the preservation of antegrade ejaculation at 3 months, with multivariable regression analysis assessing independent predictors of ejaculation preservation after adjustment for clinical parameters such as age, comorbidities, and prostate anatomical factors, including size, IPP, and SML based on cystoscopic measurement, and the presence of a median lobe. Secondary outcomes included voiding parameters, hospital stay, QoL, and perioperative complications reported according to the Clavien–Dindo classification. Statistical analysis Data were analyzed using IBM SPSS Statistics for Windows, Version 27.0 (IBM Corp., Armonk, NY, USA) version 27. Continuous variables were expressed as mean ± standard deviation and compared using a paired t-test or an independent t-test as appropriate. Non-normally distributed variables were analyzed using the Mann–Whitney U test. Categorical variables were compared using the chi-square or Fisher's exact test. To identify independent predictors of antegrade ejaculation preservation, multivariable logistic regression analysis was performed. Results of the regression analysis are reported as odds ratios (ORs) with corresponding 95% confidence intervals (CIs) and P values. Results A total of 108 patients were evaluated in this study (Fig. 1). Baseline demographic data, clinical evaluation, and prostatic characteristics are summarized in Table 1. The mean age was 62.2 ± 11.9 years (range: 49–85). The mean total prostate volume was 85.0 ± 17.5 g (range: 50–112 g). Prostates weighing <80 gm were observed in 53 patients (49.1%), whereas 55 patients (50.9%) had prostates weighing ≥80 gm.Fig. 1Study consort chart.Table 1Baseline demographic and clinical characteristicsTable 1Age (year)Mean ± SD62.2 ± 11.9Range49 – 85ComorbiditiesDiabetes mellitus44 (40.7%)Hypertension42 (38.9%)Ischemic heart disease26 (24.1%)Total prostate size (g)Mean ± SD85.0 ± 17.5Range50 – 112Prostate size<80 g53 (49.1%)≥80 g55 (50.9%)Adenomatous prostate size (g)Mean ± SD64.5 ± 14.6Range40 – 115Intravesical prostatic protrusion (IPP)Grade 1 (<5 mm)41 (38.0%)Grade 2 (5–10 mm)27 (25%)Grade 3 (>10 mm)40 (37%)Presence of median lobe46 (48%)Supramontanal length by TRUS (cm)Mean ± SD3.42 ± 0.56Range2.1–5.0Supramontanal length by cystoscopy (cm)Mean ± SD3.38 ± 0.58Range2.0–5.1SD, standard deviation; TRUS, transrectal ultrasound. Study consort chart. Table 1Baseline demographic and clinical characteristicsTable 1Age (year)Mean ± SD62.2 ± 11.9Range49 – 85ComorbiditiesDiabetes mellitus44 (40.7%)Hypertension42 (38.9%)Ischemic heart disease26 (24.1%)Total prostate size (g)Mean ± SD85.0 ± 17.5Range50 – 112Prostate size<80 g53 (49.1%)≥80 g55 (50.9%)Adenomatous prostate size (g)Mean ± SD64.5 ± 14.6Range40 – 115Intravesical prostatic protrusion (IPP)Grade 1 (<5 mm)41 (38.0%)Grade 2 (5–10 mm)27 (25%)Grade 3 (>10 mm)40 (37%)Presence of median lobe46 (48%)Supramontanal length by TRUS (cm)Mean ± SD3.42 ± 0.56Range2.1–5.0Supramontanal length by cystoscopy (cm)Mean ± SD3.38 ± 0.58Range2.0–5.1SD, standard deviation; TRUS, transrectal ultrasound. Baseline demographic and clinical characteristics SD, standard deviation; TRUS, transrectal ultrasound. Statistically significant improvement in voiding parameters was documented compared with the preoperative parameters (P < 0.001), as shown in Table 2.Table 2Functional and ejaculatory outcomesTable 2ParametersPreoperativePostoperativePIPSS22.2 ± 3.99.50 ± 4.40<0.001Quality of life5.05 ± 0.78 (4-6)1.05 ± 0.78 (0-3)<0.001Q max (mL/s)9.75 ± 1.8915.41 ± 3.38<0.001PVRU (mL)112.0 ± 65.015.0 ± 6.7<0.001EjaculationPreserved<805343 (81.1%)≥805520 (36.4%)Total10863 (58.3%)Diminished<80–10 (18.9%)≥80–35 (63.6%)Total–45 (41.6%)MSHQ-EjD-SF Q1-3 (1- 15 score)Overall12.1 ± 0.988.3 ± 1.26<0.001Patients with preserved ejaculation12.2 ±11.9 ± 1.10.587MSHQ-EjD- SF Q4 (1- 5 score)Overall1.1 ± 0.563.0 ± 0.80<0.001Patients with preserved ejaculation0.9 ± 0.211.3 ± 0.40.134IPSS, International Prostate Symptom Score; MSHO-EjD-SF, Male Sexual Health Questionnaire–Ejaculatory Dysfunction Short Form; PVRU, post voiding residual urine. Table 2Functional and ejaculatory outcomesTable 2ParametersPreoperativePostoperativePIPSS22.2 ± 3.99.50 ± 4.40<0.001Quality of life5.05 ± 0.78 (4-6)1.05 ± 0.78 (0-3)<0.001Q max (mL/s)9.75 ± 1.8915.41 ± 3.38<0.001PVRU (mL)112.0 ± 65.015.0 ± 6.7<0.001EjaculationPreserved<805343 (81.1%)≥805520 (36.4%)Total10863 (58.3%)Diminished<80–10 (18.9%)≥80–35 (63.6%)Total–45 (41.6%)MSHQ-EjD-SF Q1-3 (1- 15 score)Overall12.1 ± 0.988.3 ± 1.26<0.001Patients with preserved ejaculation12.2 ±11.9 ± 1.10.587MSHQ-EjD- SF Q4 (1- 5 score)Overall1.1 ± 0.563.0 ± 0.80<0.001Patients with preserved ejaculation0.9 ± 0.211.3 ± 0.40.134IPSS, International Prostate Symptom Score; MSHO-EjD-SF, Male Sexual Health Questionnaire–Ejaculatory Dysfunction Short Form; PVRU, post voiding residual urine. Functional and ejaculatory outcomes IPSS, International Prostate Symptom Score; MSHO-EjD-SF, Male Sexual Health Questionnaire–Ejaculatory Dysfunction Short Form; PVRU, post voiding residual urine. At the 3-month postoperative follow-up visit, antegrade ejaculation was preserved in 63 patients, representing 58.3% of the study population. Subgroup analysis demonstrated significantly higher preservation rates in patients with a prostate size <80 g than in those with a prostate size ≥80 g (81.1% vs. 36.4%, respectively). Overall, diminished or absent ejaculation occurred in 45 patients (41.6%). Ejaculatory function was evaluated using the Male Sexual Health Questionnaire for Ejaculatory Dysfunction Short Form questionnaire, where questions 1 to 3 represent the frequency of ejaculation, the strength and force of ejaculation, and the volume of ejaculation, whereas question 4 represents the bothersome symptoms from ejaculation, as shown in Table 2. Overall postoperative scores showed a statistically significant decline in questions 1–3, reflecting the frequency, strength, and volume of ejaculation (12.1 ± 0.98 vs. 8.3 ± 1.26, P < 0.001). However, no statistically significant difference was observed among patients who preserved ejaculation between preoperative and postoperative scores (P = 0.587). Similarly, the bothersome domain (question 4) increased significantly in the overall cohort but remained unchanged among patients with preserved ejaculation (P = 0.134). Perioperative complications are reported in Table 3. Complications were predominantly minor. Grade I complications occurred in 28 patients (25.9%), which are mainly mild hematuria requiring prolonged irrigation, temporary urinary retention following early catheter removal and voided successfully after a second trial without a catheter, or transient urgency or urge incontinence. Grade II complications were seen in 5 patients (4.6%), including four cases of urinary tract infection and one case of epididymo-orchitis treated conservatively. No major complications (Clavien–Dindo Grade ≥3) were recorded. No patient required alpha-blocker therapy during the 3-month follow-up period.Table 3Perioperative parametersTable 3Operative time64.62 ± 14.15Hospital stay1.34 ± 0.54Clavien–Dindo classificationGrade I28 (25.9%)Grade II5 (4.6%)Grade III A/B: IV–V0 Table 3Perioperative parametersTable 3Operative time64.62 ± 14.15Hospital stay1.34 ± 0.54Clavien–Dindo classificationGrade I28 (25.9%)Grade II5 (4.6%)Grade III A/B: IV–V0 Perioperative parameters A multivariable regression analysis was performed to assess the independent predictors of ejaculation-sparing success after adjustment for age, comorbidity, and prostate anatomical factors, as shown in Table 4. Fig. 2 presents a forest plot demonstrating the odds ratios (ORs) of the independent predictors identified in the multivariable regression model. Age, hypertension, and ischemic heart disease were not statistically significant predictors in the adjusted model (P > 0.05). Diabetes mellitus showed a borderline, nonsignificant association (OR: 0.70, 95% CI: 0.36–1.35, P = 0.099), suggesting a potential negative effect that did not reach statistical significance.Table 4Multiple regression analysis for predicting the success of ejaculation-sparing transurethral resection of the prostateTable 4Odds ratio (OR)95% confidence intervalβSEPAge0.960.911–1.011−0.0420.0270.123Diabetes mellitus0.70.458–1.069−0.3600.3380.099Hypertension0.760.396–1.458−0.2700.3270.409Ischemic heart disease0.620.300–1.282−0.4700.3630.197Prostate size0.970.946–0.995−0.0290.0120.018∗Intravesical prostatic protrusion0.750.585–0.961−0.2840.1450.023∗Presence of median lobe0.730.534–0.997−0.3210.1550.048∗Supramontanal length1.980.961–4.0790.6820.360.064P-value is statistically significant.Fig. 2Forest plot of predictors of successful ejaculation-sparing transurethral resection of the prostate. OR, odds ratio. Table 4Multiple regression analysis for predicting the success of ejaculation-sparing transurethral resection of the prostateTable 4Odds ratio (OR)95% confidence intervalβSEPAge0.960.911–1.011−0.0420.0270.123Diabetes mellitus0.70.458–1.069−0.3600.3380.099Hypertension0.760.396–1.458−0.2700.3270.409Ischemic heart disease0.620.300–1.282−0.4700.3630.197Prostate size0.970.946–0.995−0.0290.0120.018∗Intravesical prostatic protrusion0.750.585–0.961−0.2840.1450.023∗Presence of median lobe0.730.534–0.997−0.3210.1550.048∗Supramontanal length1.980.961–4.0790.6820.360.064P-value is statistically significant. Multiple regression analysis for predicting the success of ejaculation-sparing transurethral resection of the prostate P-value is statistically significant. Forest plot of predictors of successful ejaculation-sparing transurethral resection of the prostate. OR, odds ratio. In contrast, larger prostate volume was independently associated with lower odds of antegrade ejaculation preservation (OR: 0.97, 95% CI: 0.946–0.995, P = 0.018), indicating that each 1-g increase in prostate volume was associated with approximately a 3% reduction in the odds of preservation. Increased IPP was also independently associated with lower odds of preservation (OR: 0.75, 95% CI: 0.585–0.961, P = 0.023). Similarly, the presence of a median lobe was independently associated with lower odds of antegrade ejaculation preservation (OR: 0.73, 95% CI: 0.534–0.997, P = 0.048). SML showed a borderline positive association with preservation (OR: 1.98, 95% CI: 0.961–4.079, P = 0.064). Age, hypertension, and ischemic heart disease were not significantly associated with antegrade ejaculation preservation in the adjusted model. Discussion TURP is the surgical treatment of choice for a prostate size of 30–80 g. Although it provides a sustained improvement in voiding function, postoperative ejaculatory dysfunction remains one of its most frequent adverse effects.5,3,7,13 Preservation of sexual function has become an increasingly important goal in the surgical management of benign BPH, particularly among sexually active men. Vernet et al provided an improved understanding of the mechanism of ejaculation, highlighting the importance of the caudal shift of the verumontanum toward the adjacent urethral wall in forming the high-pressure chamber necessary for antegrade ejaculation.5 Further evaluation of the ejaculatory physiology suggests that the dorsal longitudinal urethral muscle complex and the distal part of the lissosphincter, particularly the smooth muscle fibers located 0.5–1 cm proximal to the verumontanum, play a role in antegrade ejaculation.14 Thus, preserving the supramontanal region during TURP maintains these structures, which form the anatomical basis for EP-TURP. Numerous modifications in surgical technique have aimed to achieve a satisfactory voiding function without sacrificing antegrade ejaculation.5,10, 11, 12,15 The present study evaluated anatomical and clinical predictors of successful ejaculation preservation following EP-TURP in a prospective cohort of 108 patients. It demonstrated that preservation of antegrade ejaculation is achievable in a substantial proportion of patients without compromising functional urinary outcomes. In this cohort, EP-TURP was performed while preserving 1 cm of urethral mucosa circumferentially around the verumontanum, including the prostatic apical urethral mucosa.10 The mean prostate size was 85.0 ± 17.5 g in this study. Antegrade ejaculation was preserved in 58.3% of patients at 3 months postoperatively. When stratified by prostate size, a higher preservation rate was observed in patients with a prostate size <80 g than in those with a prostate size ≥80 g (81.1% vs. 36.4%, respectively). Alloussi et al spared the paracollicular tissue and preserved approximately 1 cm proximal to the verumontanum or bladder neck resection alone in patients with bladder neck obstruction; in their series, the mean prostate size was 60 g with a reported success rate of 90%.12 Similarly, Zhang et al evaluated preservation of the tissue between the 5 and 7 o'clock positions extending from the bladder neck to the verumontanum, reporting a mean prostate size of 53.42 ± 9.2 g and a comparable success rate of 90%.16 In contrast, Ben Rhouma et al proposed preservation of 1 cm of urethral mucosa surrounding the supramontanal prostatic tissue, achieving a lower success rate of 65.7% in patients with a mean prostate size of approximately 60 g.17 Furthermore, Ronzoni and De Vecchis evaluated preservation of the supramontanal prostate together with more than 1 cm of the prostatic urethra distal to the verumontanum with a success rate of 80%.11 Meanwhile, Tawfeek et al reported a mean prostate size of 80 ± 17 g, demonstrating a success rate of 83%.2 These studies demonstrated anatomical preservation techniques around the verumontanum and supramontanal region to balance surgical efficacy with functional preservation. The lower overall preservation rate observed in this cohort may be explained by the larger prostate size in this cohort compared with those of these studies, while on subgroup analysis, patients with a prostate size less than 80 g showed a comparable success rate. In the present study, we evaluated clinical and anatomical factors influencing the success of EP-TURP using a standardized surgical technique. Multivariable logistic regression analysis demonstrated that anatomical characteristics were the primary determinants of ejaculatory preservation. Larger prostate volume was independently associated with a reduced likelihood of preserving antegrade ejaculation, with each incremental increase in prostate size decreasing the odds of success. Similarly, increased IPP was associated with lower preservation rates. The presence of a median lobe also emerged as an independent predictor of unfavorable ejaculatory outcomes. Diabetes mellitus showed a nonsignificant trend toward reduced preservation rates, suggesting a possible negative effect that did not reach statistical significance in this cohort. In contrast, supramontanal length demonstrated a borderline positive association with ejaculation preservation, although this finding requires further validation. Overall, these results highlight the critical role of prostatic anatomy in determining functional outcomes following EP-TURP and underscore the importance of careful preoperative patient selection and counseling. These findings correlate with the formation of the high-pressure chamber, as explained by Vernet et al, in larger prostates requiring wider resection, and closure pressure may be insufficient to produce antegrade ejaculation. Extensive resection may disrupt the critical anatomical structures involved in ejaculatory physiology. In addition to prostate size, IPP and the presence of a median lobe were identified as independent predictors of ejaculation preservation in the present study. Both were associated with a lower likelihood of maintaining antegrade ejaculation. IPP reflects the degree of median lobe protrusion into the bladder lumen and is a recognized marker of bladder outlet obstruction severity. From a surgical standpoint, significant IPP often necessitates deeper bladder neck resection and more extensive removal of the median lobe tissue. With more extensive resection, a wider prostatic fossa is formed, which lowers the resistance and pressure required for antegrade ejaculation. Chen et al, using transrectal ultrasound parameters, reported that greater prostatic resection was associated with increased rates of retrograde ejaculation following TURP. The possible explanation was that a wider prostatic fossa decreased resistance and increased retrograde ejaculation.18 Older patients are at a higher risk of ejaculation preservation failure due to the age-related changes, such as lower testosterone levels, lower semen volume, or weak muscle contractility for forceful antegrade semen ejaculation.18,19 In this study, patients’ age did not significantly impact the outcome of EP-TURP. Diabetes mellitus showed a borderline negative association with ejaculation preservation in this cohort, although it did not reach statistical significance. Ejaculatory dysfunction in diabetes mellitus is complex and multifactorial. The most common explanation is thought to be neurogenic, resulting from autonomic neuropathy that impairs sympathetic control of the emission phase and muscle contraction.20 To our knowledge, this is among the few prospective studies specifically evaluating clinical and anatomical predictors of ejaculation preservation following EP-TURP as this enables optimization of patient selection and more accurate preoperative counseling regarding functional expectations. Patients with smaller prostates and minimal intravesical protrusion appear to have the highest probability of maintaining antegrade ejaculation following surgery compared with patients with a large prostate, significant IPP, or prominent median lobes, even when ejaculation-sparing techniques are applied. Thus, anatomical preservation alone may not overcome the impact of extensive prostatic enlargement on ejaculatory function. This study has some limitations that should be acknowledged. First, the study was conducted at a single institution, which may limit the generalizability of the findings. Second, follow-up was limited to 3 months; a longer duration would allow a better assessment of the impact of the surgical technique on both voiding and ejaculatory function. Third, it was a single-arm study with no comparative procedure. Fourth, as this study primarily evaluated questionnaire-based outcomes, a detailed qualitative assessment of semen volume or force was not objectively measured. Finally, some variables did not reach statistical significance, which could be related to the sample size; therefore, we recommend a multicenter study to evaluate the different variables that may impact the success rate of the EP-TURP. Conclusion Ejaculation-sparing TURP showed promising results in preserving antegrade ejaculation without compromising voiding function in a selected group of patients. However, preservation rates are significantly influenced by anatomical factors. Larger prostate volume, increased IPP, and the presence of a median lobe are independent predictors of reduced ejaculation preservation. These findings highlight the importance of careful preoperative assessment and patient selection, allowing for more accurate counseling regarding postoperative functional expectations and optimization of surgical outcomes. Informed consent Written informed consent was obtained from all patients. Disclosure All authors have approved the final version of this manuscript. Our manuscript has not been published previously or is under consideration for publication elsewhere. Statement of ethics The study was approved by the Research Ethics Committee (FWA000017585) with the ethical approval number MS 397/2025. The study was registered on clinicaltrials.gov with a registration number: NCT07513896. Animal studies N/A. Availability of data and materials The data sets used and/or analyzed during the current study are available from the corresponding author upon reasonable request. Funding sources This study was not supported by any sponsor or funder. Conflicts of interest All authors have no conflict of interest to declare.